Hes1 Is Essential in Proliferating Ductal Cell–Mediated Development of Intrahepatic Cholangiocarcinoma
Open Access
- 1 December 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (23) , 5305-5316
Abstract
Intrahepatic cholangiocarcinoma (ICC) is frequently driven by aberrant KRAS activation and develops in the liver with chronic inflammation. Although the Notch signaling pathway is critically involved in ICC development, detailed mechanisms of Notch-driven ICC development are still unknown. Here, we use mice whose Notch signaling is genetically engineered to show that the Notch signaling pathway, specifically the Notch/Hes1 axis, plays an essential role in expanding ductular cells in the liver with chronic inflammation or oncogenic Kras activation. Activation of Notch1 enhanced the development of proliferating ductal cells (PDC) in injured livers, while depletion of Hes1 led to suppression. In correlation with PDC expansion, ICC development was also regulated by the Notch/Hes1 axis and suppressed by Hes1 depletion. Lineage-tracing experiments using EpcamcreERT2 mice further confirmed that Hes1 plays a critical role in the induction of PDC and that ICC could originate from PDC. Analysis of human ICC specimens showed PDC in nonneoplastic background tissues, confirming HES1 expression in both PDC and ICC tumor cells. Our findings provide novel direct experimental evidence that Hes1 plays an essential role in the development of ICC via PDC. Significance: This study contributes to the identification of the cells of origin that initiate ICC and suggests that HES1 may represent a therapeutic target in ICC.Keywords
All Related Versions
Funding Information
- JSPS MEXT KAKENHI (15J05143, 16K09395, 17H06803)
This publication has 51 references indexed in Scilit:
- Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in MiceGastroenterology, 2012
- Inflammation-Associated Cancer Development in Digestive Organs: Mechanisms and Roles for Genetic and Epigenetic ModulationGastroenterology, 2012
- Cholangiocarcinomas can originate from hepatocytes in miceJournal of Clinical Investigation, 2012
- KrasG12D and p53 Mutation Cause Primary Intrahepatic CholangiocarcinomaCancer Research, 2012
- Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver diseaseNature Medicine, 2012
- A robust and high-throughput Cre reporting and characterization system for the whole mouse brainNature Neuroscience, 2009
- Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liverDevelopment, 2009
- Hes genes and neurogenin regulate non-neural versus neural fate specification in the dorsal telencephalic midlineDevelopment, 2008
- Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni SyndromeCell, 2004
- Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasGenes & Development, 2001